Merck revenue falls as dollar strengthens

Merck revenue falls as dollar strengthens

(Reuters) – Merck & Co Inc reported a 2.5 percent fall in quarterly revenue, hurt by a strong dollar and declining sales of its Remicade arthritis treatment. Net income fell to $981 million, or 35 cents per share, for the fourth quarter ended Dec. 31

(Visited 1 times, 1 visits today)
7
Like
Save

Comments

Comments are disabled for this post.